Specifically, GINS2 (Psf2) overexpression has been reported in various human malignancies, including head and neck squamous cell carcinomas (HNSCC) (11), epithelial ovarian cancer (12), Osteosarcoma (13), cervical cancer (14), often correlating with aggressive tumor characteristics and poor patient prognosis. Here, GINS2 is linked to cervical cancer.